Science Day is an annual event hosted by the Saint Louis University School of Medicine Office of Research. This event features discussions with colleagues in science, topical presentations and a keynote speaker.
The third annual School of Medicine Science Day will be held from 11:30 a.m. to 5:30 p.m. Tuesday, April 23, in the Education Union Auditorium. The plenary speaker is Daniela Salvemini, Ph.D.
Salvemini is the William Beaumont Professor and chair of the Department of Pharmacology and Physiology, professor in the Department of Psychiatry and Behavioral Neuroscience, and founding director of the Institute for Translational Science at Saint Louis University.
She received her B.Sc. in pharmacology from King’s College, London, and her Ph.D. in pharmacology from the University of London. She pursued postdoctoral studies at the William Harvey Research Institute in London and at Monsanto in the Department of Discovery Pharmacology in St. Louis. Before joining Saint Louis University, Salvemini spent 15 years in the private sector, where she led drug discovery and development efforts on novel analgesics and anti-inflammatory drugs.
Salvemini’s research interests include understanding the molecular mechanisms involved in neuropathic pain states and the discovery of non-opioid therapeutics. She serves on numerous committees, including National Institutes of Health study sections (the National Institute on Drug Abuse, the National Cancer Institute and the National Institute of Neurological Disorders and Stroke) and the NIH/NINDS external consultant board for the Preclinical Screening Platform for Pain, and boards, including the United States Association for the Study of Pain.
She is the founder of BioIntervene Inc., which is developing A3 adenosine receptor agonists for neuropathic pain and neuroinflammatory diseases, and founder of the St. Louis Translational Pain Research Forum. She has published more than 250 peer-reviewed articles and has been honored with several awards, including the Novartis Award in Pharmacology, the Outstanding Scientist Award from the Saint Louis Academy of Science, the Pharmacia-ASPET Award in Experimental Therapeutics and the Mitchell B. Max Award for Neuropathic Pain from the American Academy of Neurology.
Salvemini is a fellow of the Saint Louis Academy of Science, the National Academy of Inventors, the Saint Louis University Research Institute and the American Society of Pharmacology and Experimental Therapeutics. She has been continuously funded by the National Institutes of Health, the Department of Defense, foundations and the private sector.
2024 Science Day Schedule
- 11:30 a.m. to 1 p.m.: Opening welcome and lunch
- Noon to 1 p.m.: Plenary speaker: Daniela Salvemini, Ph.D.
Title: Novel treatments in neuropathic pain states - 1 to 1:15 p.m.: Alex Reiter, Ph.D.
Department of Biomedical Engineering
Title: Assessment of tendon loading with wearable sensors - 1:15 to 1:30 p.m.: Anutosh Chakraborty, Ph.D.
Department of Pharmacology and Physiology
Title: Determining in vivo functions of novel proteins - implications in metabolic disease - 1:30 to 1:45 p.m.: Yasar Caliskan, M.D.
Department of Internal Medicine
Title: Molecular phenotyping of kidney graft ischemia-reperfusion injury - 1:45 to 2 p.m.: Sergey Korolev, Ph.D.
Department of Biochemistry and Molecular Biology
Title: Mechanism of recombination mediator proteins: from pathogens to tumor suppressors - 2 to 2:15 p.m.: Break
- 2 to 2:30 p.m.: Jaya Gnana-Prakasam, Ph.D.
Department of Ophthalmology
Title: Iron Toxicity in Retinal Degeneration - 2:30 to 2:45 p.m: John Tavis, Ph.D.
Department of Molecular Microbiology and Immunology
Title: Engineering tractable HBV polymerase derivatives for structural, mechanistic, and drug discovery studies - 2:45 to 3 p.m.: Ranjit Ray, Ph.D.
Department of Internal Medicine-Infectious Diseases
Title: Encouraging preclinical results for vaccine development against oncogenic hepatitis c virus - 3 to 3:15 p.m.: Break
- 3:15 to 3:30 p.m.: Nermi Parrow, Ph.D.
Department of Pediatrics
Title: The effect of iron restriction on disease severity in the Townes model of sickle cell anemia - 3:30 to 3:45 p.m.: Jianguo Liu, Ph.D.
Department of Internal Medicine-Infectious Diseases
Title: Discovery new host-directed therapy against mycobacterium tuberculosis infection - 3:45 to 4 p.m.: Daniel Hawiger, M.D., Ph.D.
Department of Molecular Microbiology and Immunology
Title: Surveying the landscapes of immune system in health and disease by single cell sequencing analysis within biologically interpretable dimensions - 4 to 4:30 p.m.: Award ceremony
- 4:30 to 5:30 p.m.: Student posters and reception